AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
HYDROXYCARBAMIDE in Zimbabwe
3 products registered with MCAZ — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| HYDROXYUREA 1000 TABLET, COATED; ORAL | 2023/31/6407 | NORVATIS PHARMA AG | active | 12 May 2028 |
| HYDROXYUREA 100 TABLET, COATED; ORAL | 2023/31/6406 | NOVARTIS SOUTH AFRICA (PTY) LTD | active | 12 May 2028 |
| HYDROXYUREA CAPSULE; ORAL | 2022/31/6244 | NORVATIS PHARMA AG | active | 31 Dec 2027 |
HYDROXYCARBAMIDE — MCAZ Registration Details
MCAZ (Zimbabwe) has 3 registered products containing HYDROXYCARBAMIDE, of which 3 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track HYDROXYCARBAMIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.